Having in mind that hepcidin is reliable marker of iron metabolism and that our cohort of patients is mostly consisted of newly diagnosed IBD patients with more pronounced IDA, our results are in concordance with Arnold et al. as well as Mecklenburg et al. [10, 15]. The gene discussed is HAMP; the disease is inflammatory bowel disease.